Glenmark Pharma Q2 Results : Co posts Rs 355 crore net profit on robust sales (...)
Glenmark Pharma reported Rs 340 crore net profit in Q2FY25 led by robust sales growth in India and Europe. The drugmaker reported a net loss of Rs 180 crore in the corresponding quarter of the previous year.
Site référencé: The Economic Times
The Economic Times
Gold retreats from all-time high, ends Rs 900 lower at Rs 1,02,520/10g
11/08/2025
BSE raises bar for SME to mainboard migration with higher profit, shareholder requirements
11/08/2025
Citigroup raises S&P 500 year-end target to 6,600
11/08/2025
RBI said to have sold at least $5 billion to boost rupee
11/08/2025
Like cricket, new crop of entrepreneurs coming from small towns ; focus on domestic stories and bottom-up stock ideas : Nilesh (...)
11/08/2025
2 top stock recommendations from Rajesh Bhosale
11/08/2025
